RSS   Newsletter   Contact   Advertise with us
Post Online Media

Cocrystal Pharma appoints Gary Wilcox as interim CEO

Cocrystal PharmaCocrystal Pharma, Inc., a company focused on developing novel antiviral therapeutics for human diseases, announced that Gary Wilcox will assume the role of interim CEO.
Dr. Wilcox previously served as the Chief Executive Officer of Cocrystal from 2008 to 2015. Dr. Wilcox will continue to serve as the Vice Chairman of the Board of Directors of the company.

Dr. Wilcox has over 35 years of experience in biotech companies including 14 years at Icos Corporation where he played a key role in the development of Cialis as the Executive Vice President of Operations and a member of the board of directors.

Prior to that, he served as Vice Chairman, Executive Vice President and a Director of Xoma Corporation.

Prior to Xoma, he co-founded Ingene Inc. serving as its Chairman, President and CEO prior to the merger of Ingene into Xoma. Dr. Wilcox was a Professor of Microbiology and a member of the Molecular Biology Institute at UCLA for 10 years.

He has served on 15 boards of directors including NASDAQ, New York and London stock exchange companies, as well as private technology companies.

In addition, Dr. Douglas Mayers, the Chief Medical Officer at Cocrystal, submitted his resignation.

Dr. Luz Pascual, Vice President Clinical Development, shall continue to oversee the ongoing clinical programs.




We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy